|
Decision
Point 9
|
You recommend that the patient be treated with enoxaparin (Lovenox®). The PCP asks if you could substitute a different low molecular weight heparin for the enoxaparin?
a)
No; therapeutic interchange of LMWH products is not advisable.
b) Yes;
use dalteparin
c)
Yes; use tinzaparin
d)
Yes; use hirudin
